Publication details
Inhibitors for treatment of hematological malignancies
| Authors | |
|---|---|
| Year of publication | 2023 |
| Type | Patent |
| MU Faculty or unit | |
| Publisher | United States Patent and Trademark Office |
| State | United States of America |
| Patent's number | US11648255B2 |
| Web | Link na PDF dokument na stránkách Google Patents |
| Description | A new approach to treatment of hematological malignancies. A GAB1 inhibitor for use in a method of treatment of a hematological malignancy is disclosed. The GAB1 inhibitor may be administered alone, or simultaneously or sequen-tially with a BTK inhibitor to achieve a synergistic effect. |